BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18344243)

  • 1. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways.
    Calò LA; Puato M; Schiavo S; Zanardo M; Tirrito C; Pagnin E; Balbi G; Davis PA; Palatini P; Pauletto P
    Nephrol Dial Transplant; 2008 Sep; 23(9):2804-9. PubMed ID: 18344243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling.
    Calò LA; Facco M; Davis PA; Pagnin E; Maso LD; Puato M; Caielli P; Agostini C; Pessina AC
    Hypertens Res; 2011 Sep; 34(9):1017-22. PubMed ID: 21654754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?
    Calò LA; Montisci R; Scognamiglio R; Davis PA; Pagnin E; Schiavo S; Mormino P; Semplicini A; Palatini P; D'Angelo A; Pessina AC
    J Endocrinol Invest; 2009 Nov; 32(10):832-6. PubMed ID: 19605975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.
    Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC
    J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension.
    Davis PA; Pagnin E; Dal Maso L; Caielli P; Maiolino G; Fusaro M; Paolo Rossi G; Calò LA
    Hypertens Res; 2013 Oct; 36(10):873-8. PubMed ID: 23698802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Nephrol; 2010; 23(4):472-7. PubMed ID: 20349406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling.
    Calò LA; Pagnin E; Davis PA; Sartori M; Semplicini A
    Nephrol Dial Transplant; 2003 Aug; 18(8):1518-25. PubMed ID: 12897089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early markers of inflammation in a high angiotensin II state--results of studies in Bartter's/Gitelman's syndromes.
    Davis PA; Mussap M; Pagnin E; Bertipaglia L; Savica V; Semplicini A; Calò LA
    Nephrol Dial Transplant; 2006 Jun; 21(6):1697-701. PubMed ID: 16574683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients.
    Calò LA; Davis PA; Pagnin E; Dal Maso L; Maiolino G; Seccia TM; Pessina AC; Rossi GP
    J Hypertens; 2014 Feb; 32(2):331-8. PubMed ID: 24356540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension.
    Pagnin E; Semplicini A; Sartori M; Pessina AC; Calò LA
    Am J Hypertens; 2005 Sep; 18(9 Pt 1):1200-5. PubMed ID: 16182110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodelling defences.
    Calò LA; Maiolino G; Pagnin E; Vertolli U; Davis PA
    Eur J Clin Invest; 2014 Jun; 44(6):567-72. PubMed ID: 24739026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their "pH" Enotype?
    Calò LA; Davis PA
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension.
    Calò LA; Pagnin E; Davis PA; Sartori M; Ceolotto G; Pessina AC; Semplicini A
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4153-7. PubMed ID: 15292363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho kinase and PAI-1 in Bartter's/Gitelman's syndromes: relationship to angiotensin II signaling.
    Pagnin E; Davis PA; Sartori M; Semplicini A; Pessina AC; Calò LA
    J Hypertens; 2004 Oct; 22(10):1963-9. PubMed ID: 15361768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gitelman's and Bartter's Syndromes: From Genetics to the Molecular Basis of Hypertension and More.
    Ravarotto V; Bertoldi G; Stefanelli LF; Nalesso F; Calò LA
    Kidney Blood Press Res; 2022; 47(9):556-564. PubMed ID: 35858584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin gene-related peptide, heme oxygenase-1, endothelial progenitor cells and nitric oxide-dependent vasodilation relationships in a human model of angiotensin II type-1 receptor antagonism.
    Calò LA; Davis PA; Pagnin E; Dal Maso L; Caielli P; Rossi GP
    J Hypertens; 2012 Jul; 30(7):1406-13. PubMed ID: 22573121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes.
    Calò LA
    Kidney Int; 2006 Mar; 69(6):963-6. PubMed ID: 16528244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.
    Ravarotto V; Pagnin E; Fragasso A; Maiolino G; Calò LA
    High Blood Press Cardiovasc Prev; 2015 Sep; 22(3):215-23. PubMed ID: 25759028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Gitelman's syndrome with decreased angiotensin II-forming activity.
    Eto K; Onaka U; Tsuchihashi T; Hirano T; Nakayama M; Masutani K; Hirakata H; Urata H; Yasujima M
    Hypertens Res; 2006 Jul; 29(7):545-9. PubMed ID: 17044667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.